Literature DB >> 1457005

The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins.

L Rao1, M Debbas, P Sabbatini, D Hockenbery, S Korsmeyer, E White.   

Abstract

Cooperation between the adenovirus E1A and E1B oncogenes is required for transformation of primary quiescent rodent cells. Although expression of E1A alone will stimulate cell proliferation sufficient to initiate transformed focus formation, proliferation fails to be sustained and foci degenerate. Coexpression of either the 19-kDa or 55-kDa E1B oncoproteins with E1A permits high-frequency transformation by overcoming this cytotoxic response. Without E1B 19-kDa protein expression, however, transformants remain susceptible to induction of cell death. Rapid loss of viability is coincident with nucleolytic cleavage of DNA in intranucleosomal regions and chromatin condensation, hallmarks of programmed cell death (apoptosis). Furthermore, overexpression of a known suppressor of apoptosis, the Bcl-2 protooncogene, can rescue E1A-induced focus degeneration. Thus E1A-dependent stimulation of cell proliferation is accompanied by apoptosis and thereby insufficient to singly induce transformation. High-frequency transformation requires a second function encoded by the E1B 19-kDa protein to block apoptosis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1457005      PMCID: PMC49787          DOI: 10.1073/pnas.89.16.7742

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  46 in total

Review 1.  Programmed cell death: apoptosis and oncogenesis.

Authors:  G T Williams
Journal:  Cell       Date:  1991-06-28       Impact factor: 41.582

Review 2.  Transcriptional and transforming activities of the adenovirus E1A proteins.

Authors:  T Shenk; J Flint
Journal:  Adv Cancer Res       Date:  1991       Impact factor: 6.242

3.  Adenovirus E1B 19-kilodalton protein overcomes the cytotoxicity of E1A proteins.

Authors:  E White; R Cipriani; P Sabbatini; A Denton
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

Review 4.  Programmed cell death in the immune system.

Authors:  J J Cohen
Journal:  Adv Immunol       Date:  1991       Impact factor: 3.543

5.  Genetic studies with tumorigenic adenoviruses. I. Isolation of cytocidal (cyt) mutants of adenovirus type 12.

Authors:  N Takemori; J L Riggs; C Aldrich
Journal:  Virology       Date:  1968-12       Impact factor: 3.616

6.  Expression of region E1b of human adenoviruses in the absence of region E1a is not sufficient for complete transformation.

Authors:  P Van den Elsen; A Houweling; A Van der Eb
Journal:  Virology       Date:  1983-07-30       Impact factor: 3.616

7.  The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis.

Authors:  N Itoh; S Yonehara; A Ishii; M Yonehara; S Mizushima; M Sameshima; A Hase; Y Seto; S Nagata
Journal:  Cell       Date:  1991-07-26       Impact factor: 41.582

8.  The E1B 19,000-molecular-weight protein of group C adenoviruses prevents tumor necrosis factor cytolysis of human cells but not of mouse cells.

Authors:  L R Gooding; L Aquino; P J Duerksen-Hughes; D Day; T M Horton; S P Yei; W S Wold
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

9.  The 19-kilodalton adenovirus E1B transforming protein inhibits programmed cell death and prevents cytolysis by tumor necrosis factor alpha.

Authors:  E White; P Sabbatini; M Debbas; W S Wold; D I Kusher; L R Gooding
Journal:  Mol Cell Biol       Date:  1992-06       Impact factor: 4.272

10.  Mutations in the gene encoding the adenovirus early region 1B 19,000-molecular-weight tumor antigen cause the degradation of chromosomal DNA.

Authors:  E White; T Grodzicker; B W Stillman
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

View more
  197 in total

1.  p53-Independent and -dependent requirements for E1B-55K in adenovirus type 5 replication.

Authors:  J N Harada; A J Berk
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

2.  Roles for the E4 orf6, orf3, and E1B 55-kilodalton proteins in cell cycle-independent adenovirus replication.

Authors:  F D Goodrum; D A Ornelles
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

Review 3.  Mechanisms of viral pathogenesis in rheumatic disease.

Authors:  A Perl
Journal:  Ann Rheum Dis       Date:  1999-08       Impact factor: 19.103

4.  Suppression of E1A-mediated transformation by the p50E4F transcription factor.

Authors:  E R Fernandes; R J Rooney
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

5.  Infectious hematopoietic necrosis virus matrix protein inhibits host-directed gene expression and induces morphological changes of apoptosis in cell cultures.

Authors:  P P Chiou; C H Kim; P Ormonde; J A Leong
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

6.  Inactivation of p21 by E1A leads to the induction of apoptosis in DNA-damaged cells.

Authors:  D Chattopadhyay; M K Ghosh; A Mal; M L Harter
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

Review 7.  Does the antitumor adenovirus ONYX-015/dl1520 selectively target cells defective in the p53 pathway?

Authors:  B R Dix; S J Edwards; A W Braithwaite
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

8.  Effect of enforced expression of human bcl-2 on Japanese encephalitis virus-induced apoptosis in cultured cells.

Authors:  C L Liao; Y L Lin; J J Wang; Y L Huang; C T Yeh; S H Ma; L K Chen
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

9.  Horizontal transfer of oncogenes by uptake of apoptotic bodies.

Authors:  A Bergsmedh; A Szeles; M Henriksson; A Bratt; M J Folkman; A L Spetz; L Holmgren
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

10.  Inhibition of Programmed Cell Death in Tobacco Plants during a Pathogen-Induced Hypersensitive Response at Low Oxygen Pressure.

Authors:  R. Mittler; V. Shulaev; M. Seskar; E. Lam
Journal:  Plant Cell       Date:  1996-11       Impact factor: 11.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.